Germany's Merck Seeks Global Growth In Fertility Drugs And Technologies
This article was originally published in Scrip
Executive Summary
The diversified German group Merck KGaA believes demographic patterns for the world's seven billion-plus population bode well for fertility treatments and technologies, and is positioning itself accordingly.